Viral Vector Development
Get your product to patients. Now.
The rapidly expanding number of biotechs focusing on Gene Therapies means many products require manufacturing and distribution to patients. There is no one-size-fits-all solutions for Viral Vector manufacturing. Just like the therapy you develop, you require a tailored approach.
- Translational activities to create GMP compliant manufacturing
- Process design and optimisation
- Scale-up to clinically relevant volumes
- Automation and closed processes
- Pre-clinical or toxicology study material
- Phase I, Phase II clinical trial material
Talk to NecstGen today about your needs for:
- Lentivirusses (LV)
- Adeno-associated virusses (AAV)
- Oncolytic virusesses